Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Mylan NV Ord Shs (MYL)

Mylan NV Ord Shs (MYL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,749,943
  • Shares Outstanding, K 515,870
  • Annual Sales, $ 11,434 M
  • Annual Income, $ 352,500 K
  • 60-Month Beta 1.80
  • Price/Sales 0.83
  • Price/Cash Flow 2.13
  • Price/Book 0.80

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 1.14
  • Number of Estimates 7
  • High Estimate 1.18
  • Low Estimate 1.08
  • Prior Year 1.25
  • Growth Rate Est. (year over year) -8.80%

Price Performance

See More
Period Period Low Period High Performance
1-Month
18.10 +2.32%
on 10/02/19
22.05 -15.99%
on 09/16/19
-3.17 (-14.62%)
since 09/13/19
3-Month
17.31 +6.99%
on 08/07/19
22.90 -19.13%
on 09/13/19
-0.70 (-3.64%)
since 07/12/19
52-Week
16.63 +11.37%
on 05/31/19
37.56 -50.69%
on 11/06/18
-13.59 (-42.32%)
since 10/12/18

Most Recent Stories

More News
Mylan Nv (MYL) Approaches New Upside Target of $19.07

Mylan Nv (NASDAQ:MYL) has opened bullishly above the pivot of $18.55 today and has reached the first level of resistance at $18.78. Investors may be interested in a cross of the next upside pivot targets...

MYL : 18.52 (-2.01%)
Why the Earnings Surprise Streak Could Continue for Mylan (MYL)

Mylan (MYL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

MYL : 18.52 (-2.01%)
Theravance Pipeline Strong, Dependence on Yupelri a Concern

Theravance's (TBPH) newly-launched COPD drug Yupelri is witnessing a solid adoption while its pipeline programs are also progressing well. However, excessive reliance on Yupelri for revenues is a woe.

JNJ : 130.72 (-0.46%)
GSK : 42.17 (-0.02%)
TBPH : 17.20 (-3.04%)
MYL : 18.52 (-2.01%)
Mylan (MYL) to Pay $30M to Settle SEC Charges for EpiPen

Mylan (MYL) sinks after the SEC charges it for misclassification of EpiPen.

PFE : 36.30 (+0.53%)
MYL : 18.52 (-2.01%)
TEVA : 6.73 (-2.46%)
RDY : 37.36 (+0.05%)
SmarTrend Watching for Potential Rebound in Shares of Mylan Nv After 1.02% Loss

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $19.05 to a high of $19.37. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $19.23 on...

MYL : 18.52 (-2.01%)
Mylan Nv Set to Possibly Rebound After Yesterday's Selloff of 1.02%

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $19.05 to a high of $19.37. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $19.23 on...

MYL : 18.52 (-2.01%)
Watch for Shares of Mylan Nv (MYL) to Approach Support at $18.90

Shares of Mylan Nv (NASDAQ:MYL) have bearishly opened below the pivot of $19.56 today and have reached the first support level of $19.24. Analysts will be watching for a cross of the next downside pivot...

MYL : 18.52 (-2.01%)
Mylan agrees to pay $30M in SEC EpiPen settlement

PITTSBURGH (AP) — Mylan has agreed to pay $30 million in a settlement tied to its failure to tell investors about a Justice Department investigation into whether the company overcharged Medicaid for...

MYL : 18.52 (-2.01%)
Mylan Finalizes Previously Disclosed Settlement with U.S. Securities and Exchange Commission

Mylan N.V. (NASDAQ: MYL) today announced that it has finalized a previously disclosed civil settlement with the U.S. Securities and Exchange Commission ("SEC"). On July 29, 2019, the Company disclosed...

MYL : 18.52 (-2.01%)
Mylan Nv Falls 3.07% on Heavy Volume: Watch For Potential Rebound

Mylan Nv (NASDAQ:MYL) traded in a range yesterday that spanned from a low of $19.83 to a high of $20.35. Yesterday, the shares fell 3.1%, which took the trading range below the 3-day low of $20.60 on...

MYL : 18.52 (-2.01%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More Share

Trade MYL with:

Business Summary

Mylan NV is a pharmaceutical company. The company develops, licenses, manufactures, markets and distributes generic and specialty pharmaceuticals. It operates primarily in the United States, Canada, Europe, the Middle East, Africa, India, Australia, Japan and New Zealand. Mylan NV, formerly known as...

See More

Key Turning Points

2nd Resistance Point 19.08
1st Resistance Point 18.80
Last Price 18.52
1st Support Level 18.34
2nd Support Level 18.16

See More

52-Week High 37.56
Fibonacci 61.8% 29.56
Fibonacci 50% 27.10
Fibonacci 38.2% 24.63
Last Price 18.52
52-Week Low 16.63

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar